BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-536

  1. 4,169 Posts.
    lightbulb Created with Sketch. 5429
    The results - are that the product performs in line with the best products out there, with less side effects, and that the australian vehicle performed as expected, while the US vehicle performed extraordinarily high...... meaning that Permatex by itself is not a cure - otherwise the austrralian permatex would have similar results....... so what we are saying is.... the only reasonable, rational , logical reason, is that something went wrong either with the vehicle in Aus - if the vehicle itself is a cure..... or the US vehicle manufactured today, is going to perform the same as the Aus vehicle.


    no matter what way you cut it....... the results without looking at the baseline, are on par with the global competitors today.

    How big will the correction be, when Phase 3 correlates that...... or.......at some point shortly they manage to identify probable cause.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
38.0¢
Change
0.055(16.9%)
Mkt cap ! $687.8M
Open High Low Value Volume
33.0¢ 38.0¢ 33.0¢ $7.103M 19.63M

Buyers (Bids)

No. Vol. Price($)
5 134000 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 650314 19
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.